Spatial mapping of human hematopoiesis at single-cell resolution reveals aging-associated topographic remodeling.

Journal: Blood
PMID:

Abstract

The spatial anatomy of hematopoiesis in the bone marrow (BM) has been extensively studied in mice and other preclinical models, but technical challenges have precluded a commensurate exploration in humans. Institutional pathology archives contain thousands of paraffinized BM core biopsy tissue specimens, providing a rich resource for studying the intact human BM topography in a variety of physiologic states. Thus, we developed an end-to-end pipeline involving multiparameter whole tissue staining, in situ imaging at single-cell resolution, and artificial intelligence-based digital whole slide image analysis and then applied it to a cohort of disease-free samples to survey alterations in the hematopoietic topography associated with aging. Our data indicate heterogeneity in marrow adipose tissue (MAT) content within each age group and an inverse correlation between MAT content and proportions of early myeloid and erythroid precursors, irrespective of age. We identify consistent endosteal and perivascular positioning of hematopoietic stem and progenitor cells (HSPCs) with medullary localization of more differentiated elements and, importantly, uncover new evidence of aging-associated changes in cellular and vascular morphologies, microarchitectural alterations suggestive of foci with increased lymphocytes, and diminution of a potentially active megakaryocytic niche. Overall, our findings suggest that there is topographic remodeling of human hematopoiesis associated with aging. More generally, we demonstrate the potential to deeply unravel the spatial biology of normal and pathologic human BM states using intact archival tissue specimens.

Authors

  • Aleksandr Sarachakov
    BostonGene Corporation, Waltham, MA.
  • Arina Varlamova
    BostonGene Corporation, Waltham, MA.
  • Viktor Svekolkin
    BostonGene Corporation, Waltham, MA.
  • Margarita Polyakova
    BostonGene Corporation, Waltham, MA.
  • Itzel Valencia
    Multiparametric In Situ Imaging Laboratory, Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY.
  • Caitlin Unkenholz
    Multiparametric In Situ Imaging Laboratory, Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY.
  • Tania Pannellini
    Multiparametric In Situ Imaging Laboratory, Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY.
  • Ilia Galkin
    BostonGene Corporation, Waltham, MA.
  • Pavel Ovcharov
    BostonGene Corporation, Waltham, MA.
  • Dmitrii Tabakov
    BostonGene Corporation, Waltham, MA.
  • Ekaterina Postovalova
    BostonGene Corporation, Waltham, MA.
  • Nara Shin
    BostonGene Corporation, Waltham, MA.
  • Isha Sethi
    BostonGene Corporation, Waltham, MA.
  • Alexander Bagaev
    BostonGene Corporation, Waltham, MA.
  • Tomer Itkin
    Division of Regenerative Medicine, Department of Medicine, Hartman Institute for Therapeutic Organ Regeneration, Ansary Stem Cell Institute, Weill Cornell Medicine, New York, NY.
  • Genevieve Crane
    Department of Laboratory Medicine, Cleveland Clinic, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland, OH.
  • Michael Kluk
    Institute for Precision Medicine.
  • Julia Geyer
    Division of Hematopathology, Department of Pathology and Laboratory Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY.
  • Giorgio Inghirami
    Division of Hematopathology, Department of Pathology and Laboratory Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY.
  • Sanjay Patel
    Department of Urology, University of Oklahoma, Oklahoma City, Oklahoma.